Pegylated Liposomal Doxorubicin in Recurrent Malignant Glioma: Analysis of a Case Series

Publisher： Karger

E-ISSN： 1423-0232|72|5-6|302-307

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.5-6, 2008-01, pp. : 302-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prolonged pegylated liposomal doxorubicin treatment for recurrent pelvic cancers: a feasibility study

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 7, 2015-07 ,pp. : 776-780

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of the Combination of Trabectedin and Pegylated Liposomal Doxorubicin in a BRCA2 Mutation Carrier with Recurrent Platinum-Sensitive Ovarian Cancer

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-05 ,pp. : 433-437

Karger

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin with Vinorelbine in Metastatic Breast Carcinoma

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 23-30

Karger

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin in Combination with Hyperthermia for Treatment of Skin Metastases of Breast Carcinoma: A Case Report

By  

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 166-168

Karger

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin-Induced Acute Transient Encephalopathy in a Patient with Breast Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 228-232

Karger

Access to resources Recommend Favorite